Bismuth Subcitrate Potassium, Metronidazole, And Tetracycline Hydrochloride
Product Images NDC 61269-385

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole, And Tetracycline Hydrochloride (NDC 61269-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pylera 01)

Chemical Structure (Pylera 01)
Chemical structure diagram depicting the molecular formula of an active pharmaceutical ingredient, showing a nitro group (NO2), a hydroxyl group (OH), and methyl (CH3) substituents attached to a heterocyclic ring containing nitrogen atoms.*
FDA Label Image

Chemical Structure (Pylera 02)

Chemical Structure (Pylera 02)
Chemical structure diagram of the active ingredient tetracycline hydrochloride, showing its molecular arrangement including hydroxyl, amine, and methyl groups along with the hydrochloride component.*
FDA Label Image

Principal Display Panel (120 Capsule Blister Card Box)

Principal Display Panel (120 Capsule Blister Card Box)
Packaging label for Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride Capsules 140 mg/125 mg/125 mg by H2-Pharma, LLC. The label indicates a 10 Day Therapy PAK containing 120 capsules in 10 blister cards, with each blister card containing 3 capsules. The product is distributed by H2-Pharma, LLC, Montgomery, AL, and made in Canada. The label includes dosage information and states the product is intended for eradicating Helicobacter pylori.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.